This topic contains a solution. Click here to go to the answer

Author Question: Abnormal processing of which neurotransmitter has been implicated in cognitive decline in normal ... (Read 53 times)

stephzh

  • Hero Member
  • *****
  • Posts: 556
Abnormal processing of which neurotransmitter has been implicated in cognitive decline in normal aging, Alzheimer's disease, and schizophrenia?
 
  a. serotonin
  b. dopamine
  c. acetylcholine
  d. cerebraltonin

Question 2

Research has found that declines in the dopaminergic system are related to declines in memory and tasks.
 
  a. long-term; speed
  b. semantic; attention
  c. episodic; thought
  d. episodic; speed



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lauravaras

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

ANSWER: a

Answer to Question 2

ANSWER: d




stephzh

  • Member
  • Posts: 556
Reply 2 on: Aug 23, 2018
Excellent


CAPTAINAMERICA

  • Member
  • Posts: 325
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library